What is Ocular Therapeutix's EPS (basic)?

Ocular Therapeutix (OCUL) reported EPS (basic) of -$0.40 in Q1 2026.

How has Ocular Therapeutix's EPS (basic) changed year-over-year?

Ocular Therapeutix's EPS (basic) decreased by 5.3% year-over-year, from -$0.38 to -$0.40.

What is the long-term trend for Ocular Therapeutix's EPS (basic)?

Over 4 years (2021 to 2025), Ocular Therapeutix's EPS (basic) has grown at a 99.3% compound annual growth rate (CAGR), from -$0.09 to -$1.42.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ocular Therapeutix OCUL EPS (Basic)

EPS (Basic) at other companies

Regeneron PharmaceuticalsREGN

$6.99-7.8%

Bausch + LombBLCO

-$0.20+66.7%

Tarsus Pharmaceuticals, Inc.TARS

-$0.16+75.0%

Kodiak Sciences IncKOD

-$0.94+13.8%

Ultragenyx PharmaceuticalRARE

-$1.84-17.2%

PBH

Prestige Consumer HealthcarePBH

$1.13+11.9%

Other financials

Income statement

See full

Revenue$10.8M+0.8%

Gross profit$9.5M+0.2%

Operating income-$93.3M-46.0%

Net income-$88.6M-38.3%

EPS (diluted)-$0.40-5.3%

Balance sheet

See full

Cash & equivalents$666.7M+90.7%

Total debt$79.5M+4.2%

Total equity$581.6M+119%

Total assets$732.5M+80.5%

Cash flow

See full

Operating cash flow-$66.0M-47.7%

CapEx$4.7M+141%

Free cash flow-$70.7M-51.6%

Valuation

See full

Market cap$2.21B+58.2%

Enterprise value$1.63B+40.8%

P/S42.6×+19.1×

Profitability

See full

Gross margin87.2%-3.4pp

Operating margin-575.4%+1,233pp

Net margin-558.2%+1,493pp

FCF margin-463%+2,860pp

Returns & leverage

See full

Return on equity-68.6%+17.0pp

Debt / equity0.1×-0.2×

Current ratio14.8×+4.6×

Where this comes from

Reported directly by Ocular Therapeutix in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ocular Therapeutix's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ocular Therapeutix's EPS (basic)?: Ocular Therapeutix (OCUL) reported EPS (basic) of -$0.40 in Q1 2026.
How has Ocular Therapeutix's EPS (basic) changed year-over-year?: Ocular Therapeutix's EPS (basic) decreased by 5.3% year-over-year, from -$0.38 to -$0.40.
What is the long-term trend for Ocular Therapeutix's EPS (basic)?: Over 4 years (2021 to 2025), Ocular Therapeutix's EPS (basic) has grown at a 99.3% compound annual growth rate (CAGR), from -$0.09 to -$1.42.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.